ORCHID PHARMA LTD Share Price, Forecast, News and Quotes - Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD Share Price   (ORCHID)

Here is the latest stock price and chart of Orchid Chemicals. For more details, see the Orchid Chemicals company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jan 19, 2017 (Close)
Price (Rs)28.65 Open (Rs) 28.60 High (Rs) 28.95 Low (Rs) 28.55
% Change0.35 Volume 56,141 Value (Rs) 1,613,006 52-Week H/L 47.60 / 23.70
Live NSE Quotes Jan 19, 2017 3:24:58 PM
Price (Rs)28.65 Open (Rs) 28.60 High (Rs) 28.95 Low (Rs) 28.45
% Change0.35 Volume 149,781 Value (Rs) 4,289,728 52-Week H/L 75.55 / 42.50
Valuation
EPS (Rs)* -35.93 P/E Ratio (x) NM Market Cap (Rs m) 2,442.70 P/BV (x) 0.64
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
ORCHID PHARMA LTD Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new


Today's Market

Sensex Ends Marginally Positive; Energy Stocks Up 2%(Closing)

The Indian share markets finished the day on flat note amid mixed Asian cues. At the closing bell, the BSE Sensex closed higher by 51 points, whereas the NSE Nifty finished higher by 18 points.

Related Views On News

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - NOVARTIS COMPARISON

Compare Company With Charts

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS